Evidence map›Paper›PMID 36823089›Full record

ArticleInternal medicine (Tokyo, Japan)2023

First Case Report of Peritoneal Dialysis-associated Peritonitis Caused by Lysinibacillus sphaericus.

Teruhisa Kinoshita, Shoko Sahara, Tomomi Amano, Masashi Ito, Takashi Sakakibara, Norio Takimoto, Yukari Osada, Keisuke Oka

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Peritoneal Dialysis-Related Peritonitis Caused byCase reports in nephrology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Teruhisa KinoshitaDepartment of Pharmacy, Kariya Toyota General Hospital, Japan.
Shoko SaharaDepartment of Pharmacy, Kariya Toyota General Hospital, Japan.
Tomomi AmanoDepartment of Clinical Laboratory, Kariya Toyota General Hospital, Japan.
Masashi ItoDepartment of Pharmacy, Takahama Toyota Hospital, Japan.
Takashi SakakibaraDepartment of Pharmacy, Kariya Toyota General Hospital, Japan.
Norio TakimotoDepartment of Pharmacy, Kariya Toyota General Hospital, Japan.
Yukari OsadaDepartment of Clinical Laboratory, Nagoya University Hospital, Japan.
Keisuke OkaDepartment of Infectious Diseases, Nagoya University Hospital, Japan.
Kariya Toyota General Hospital · JPNagoya University Hospital · JPToyota Memorial Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We herein report a case of peritoneal dialysis-associated peritonitis caused by Lysinibacillus sphaericus in a 40s-year-old patient. Treatment was initiated with intermittent intraperitoneal cefazolin and ceftazidime. Later, both peritoneal dialysate and blood cultures detected L. sphaericus, so the antibiotic was changed to ampicillin (ABPC). The patient was treated with a combination of intraperitoneal intermittent and intravenous ABPC for 7 days, followed by 14 days of amoxicillin. The patient experienced no adverse events and no recurrence for 30 days. The patient had four dogs, and the infection was deemed likely to have been caused by environmental contamination and inadequate catheter replacement.

Indexed as

Anti-Bacterial AgentsPeritoneal DialysisPeritoneal Dialysis, Continuous AmbulatoryPeritonitisAdultAmpicillinBacillaceaeHumansAmpicillinAnti-Bacterial AgentsLysinibacillus sphaericusperitoneal dialysisperitonitis

Identifiers

PMID36823089
PMCPMC10602840
OpenAlexW4321440733

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.